CAR T Cell Manufacturing from Naive/Stem Memory T-Lymphocytes Enhances Antitumor Responses while Curtailing Cytokine Release Syndrome

Scientists investigated the efficacy and safety profiles of CAR T cell products generated from pre-selected naive/stem memory T cells, as compared to unselected T cells.